PAPOA_HUMAN - dbPTM
PAPOA_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PAPOA_HUMAN
UniProt AC P51003
Protein Name Poly(A) polymerase alpha
Gene Name PAPOLA
Organism Homo sapiens (Human).
Sequence Length 745
Subcellular Localization Cytoplasm. Nucleus. The 90 kDa form is nuclear while the 100 kDa and the 106 kDa forms are both nuclear and cytoplasmic.
Protein Description Polymerase that creates the 3'-poly(A) tail of mRNA's. Also required for the endoribonucleolytic cleavage reaction at some polyadenylation sites. May acquire specificity through interaction with a cleavage and polyadenylation specificity factor (CPSF) at its C-terminus..
Protein Sequence MPFPVTTQGSQQTQPPQKHYGITSPISLAAPKETDCVLTQKLIETLKPFGVFEEEEELQRRILILGKLNNLVKEWIREISESKNLPQSVIENVGGKIFTFGSYRLGVHTKGADIDALCVAPRHVDRSDFFTSFYDKLKLQEEVKDLRAVEEAFVPVIKLCFDGIEIDILFARLALQTIPEDLDLRDDSLLKNLDIRCIRSLNGCRVTDEILHLVPNIDNFRLTLRAIKLWAKRHNIYSNILGFLGGVSWAMLVARTCQLYPNAIASTLVHKFFLVFSKWEWPNPVLLKQPEECNLNLPVWDPRVNPSDRYHLMPIITPAYPQQNSTYNVSVSTRMVMVEEFKQGLAITDEILLSKAEWSKLFEAPNFFQKYKHYIVLLASAPTEKQRLEWVGLVESKIRILVGSLEKNEFITLAHVNPQSFPAPKENPDKEEFRTMWVIGLVFKKTENSENLSVDLTYDIQSFTDTVYRQAINSKMFEVDMKIAAMHVKRKQLHQLLPNHVLQKKKKHSTEGVKLTALNDSSLDLSMDSDNSMSVPSPTSATKTSPLNSSGSSQGRNSPAPAVTAASVTNIQATEVSVPQVNSSESSGGTSSESIPQTATQPAISPPPKPTVSRVVSSTRLVNPPPRSSGNAATSGNAATKIPTPIVGVKRTSSPHKEESPKKTKTEEDETSEDANCLALSGHDKTEAKEQLDTETSTTQSETIQTAASLLASQKTSSTDLSDIPALPANPIPVIKNSIKLRLNR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Phosphorylation--MPFPVTTQGSQQT
--CCCCCCCCCCCCC
17.4026074081
7O-linked_Glycosylation-MPFPVTTQGSQQTQ
-CCCCCCCCCCCCCC
31.0328510447
7Phosphorylation-MPFPVTTQGSQQTQ
-CCCCCCCCCCCCCC
31.0326074081
10PhosphorylationFPVTTQGSQQTQPPQ
CCCCCCCCCCCCCCC
14.8626074081
13PhosphorylationTTQGSQQTQPPQKHY
CCCCCCCCCCCCCCC
35.0926074081
20PhosphorylationTQPPQKHYGITSPIS
CCCCCCCCCCCCCCC
19.7723927012
23PhosphorylationPQKHYGITSPISLAA
CCCCCCCCCCCCCCC
24.8829255136
24PhosphorylationQKHYGITSPISLAAP
CCCCCCCCCCCCCCC
20.5129255136
27PhosphorylationYGITSPISLAAPKET
CCCCCCCCCCCCCCC
18.4923927012
32AcetylationPISLAAPKETDCVLT
CCCCCCCCCCCCCHH
69.4026051181
32UbiquitinationPISLAAPKETDCVLT
CCCCCCCCCCCCCHH
69.40-
41UbiquitinationTDCVLTQKLIETLKP
CCCCHHHHHHHHHCC
46.31-
47UbiquitinationQKLIETLKPFGVFEE
HHHHHHHCCCCCCCC
45.80-
67UbiquitinationRRILILGKLNNLVKE
HHHHHHHHHHHHHHH
44.59-
83UbiquitinationIREISESKNLPQSVI
HHHHHHCCCCCHHHH
59.46-
88PhosphorylationESKNLPQSVIENVGG
HCCCCCHHHHHHCCC
24.1120068231
99PhosphorylationNVGGKIFTFGSYRLG
HCCCEEEEECCEECC
30.4720068231
102PhosphorylationGKIFTFGSYRLGVHT
CEEEEECCEECCCCC
11.6820068231
103PhosphorylationKIFTFGSYRLGVHTK
EEEEECCEECCCCCC
15.3820068231
109PhosphorylationSYRLGVHTKGADIDA
CEECCCCCCCCCCCE
28.8527422710
110UbiquitinationYRLGVHTKGADIDAL
EECCCCCCCCCCCEE
36.90-
118GlutathionylationGADIDALCVAPRHVD
CCCCCEEEECCCCCC
2.3522555962
136UbiquitinationFFTSFYDKLKLQEEV
HHHHHHHHHHHHHHH
35.8221890473
136 (in isoform 2)Ubiquitination-35.8221890473
138UbiquitinationTSFYDKLKLQEEVKD
HHHHHHHHHHHHHHH
54.59-
144AcetylationLKLQEEVKDLRAVEE
HHHHHHHHHHHHHHH
55.0925953088
144UbiquitinationLKLQEEVKDLRAVEE
HHHHHHHHHHHHHHH
55.09-
144 (in isoform 2)Ubiquitination-55.0921890473
152 (in isoform 1)Ubiquitination-9.3821890473
160 (in isoform 1)Ubiquitination-2.1921890473
188PhosphorylationDLDLRDDSLLKNLDI
CCCCCCCHHHHCCCH
39.6324719451
191UbiquitinationLRDDSLLKNLDIRCI
CCCCHHHHCCCHHHH
61.84-
191 (in isoform 2)Ubiquitination-61.8421890473
207 (in isoform 1)Ubiquitination-14.4621890473
307PhosphorylationWDPRVNPSDRYHLMP
CCCCCCHHHCCCCCE
29.5324275569
310PhosphorylationRVNPSDRYHLMPIIT
CCCHHHCCCCCEEEC
12.33-
317PhosphorylationYHLMPIITPAYPQQN
CCCCEEECCCCCCCC
11.5523403867
355UbiquitinationTDEILLSKAEWSKLF
CHHHHCCHHHHHHHH
50.74-
360UbiquitinationLSKAEWSKLFEAPNF
CCHHHHHHHHHCCCH
59.2621890473
370UbiquitinationEAPNFFQKYKHYIVL
HCCCHHHHCCEEEEE
51.62-
372UbiquitinationPNFFQKYKHYIVLLA
CCHHHHCCEEEEEEE
36.65-
376 (in isoform 1)Ubiquitination-2.5621890473
380PhosphorylationHYIVLLASAPTEKQR
EEEEEEEECCCHHHH
34.45-
444SumoylationWVIGLVFKKTENSEN
HHHEEEEECCCCCCC
51.83-
444SumoylationWVIGLVFKKTENSEN
HHHEEEEECCCCCCC
51.83-
445SumoylationVIGLVFKKTENSENL
HHEEEEECCCCCCCE
50.00-
445SumoylationVIGLVFKKTENSENL
HHEEEEECCCCCCCE
50.00-
474PhosphorylationVYRQAINSKMFEVDM
HHHHHHHCCHHHHHH
21.2728851738
482AcetylationKMFEVDMKIAAMHVK
CHHHHHHHHHHHHHC
25.4015611779
486SulfoxidationVDMKIAAMHVKRKQL
HHHHHHHHHHCHHHH
2.4930846556
489AcetylationKIAAMHVKRKQLHQL
HHHHHHHCHHHHHHH
38.9225953088
509PhosphorylationLQKKKKHSTEGVKLT
HHCCCCCCCCCCEEE
36.7130576142
510PhosphorylationQKKKKHSTEGVKLTA
HCCCCCCCCCCEEEE
36.1620068231
516PhosphorylationSTEGVKLTALNDSSL
CCCCCEEEECCCCCC
24.3120873877
521PhosphorylationKLTALNDSSLDLSMD
EEEECCCCCCCCCCC
31.5620873877
522PhosphorylationLTALNDSSLDLSMDS
EEECCCCCCCCCCCC
28.8525137130
526PhosphorylationNDSSLDLSMDSDNSM
CCCCCCCCCCCCCCC
21.8830278072
529PhosphorylationSLDLSMDSDNSMSVP
CCCCCCCCCCCCCCC
30.0130278072
532PhosphorylationLSMDSDNSMSVPSPT
CCCCCCCCCCCCCCC
19.8820873877
534PhosphorylationMDSDNSMSVPSPTSA
CCCCCCCCCCCCCCC
30.6030278072
537PhosphorylationDNSMSVPSPTSATKT
CCCCCCCCCCCCCCC
38.3630278072
539PhosphorylationSMSVPSPTSATKTSP
CCCCCCCCCCCCCCC
35.0230278072
540PhosphorylationMSVPSPTSATKTSPL
CCCCCCCCCCCCCCC
37.0130278072
542PhosphorylationVPSPTSATKTSPLNS
CCCCCCCCCCCCCCC
34.3230278072
544PhosphorylationSPTSATKTSPLNSSG
CCCCCCCCCCCCCCC
31.0830278072
545PhosphorylationPTSATKTSPLNSSGS
CCCCCCCCCCCCCCC
29.0121955146
549PhosphorylationTKTSPLNSSGSSQGR
CCCCCCCCCCCCCCC
43.7028450419
550PhosphorylationKTSPLNSSGSSQGRN
CCCCCCCCCCCCCCC
41.4428450419
552PhosphorylationSPLNSSGSSQGRNSP
CCCCCCCCCCCCCCC
22.8028450419
553PhosphorylationPLNSSGSSQGRNSPA
CCCCCCCCCCCCCCC
39.9323927012
558PhosphorylationGSSQGRNSPAPAVTA
CCCCCCCCCCCCCEE
22.5225332170
569PhosphorylationAVTAASVTNIQATEV
CCEEEEEEEEEEEEE
24.9024275569
586PhosphorylationPQVNSSESSGGTSSE
CCCCCCCCCCCCCCC
35.9125332170
605PhosphorylationTATQPAISPPPKPTV
CCCCCCCCCCCCCCC
33.2024719451
617PhosphorylationPTVSRVVSSTRLVNP
CCCEEEEECCEECCC
24.1222199227
618PhosphorylationTVSRVVSSTRLVNPP
CCEEEEECCEECCCC
13.1126699800
619PhosphorylationVSRVVSSTRLVNPPP
CEEEEECCEECCCCC
22.1027273156
628PhosphorylationLVNPPPRSSGNAATS
ECCCCCCCCCCCCCC
48.6629116813
629PhosphorylationVNPPPRSSGNAATSG
CCCCCCCCCCCCCCC
37.0329116813
634PhosphorylationRSSGNAATSGNAATK
CCCCCCCCCCCCCCC
34.4529116813
635PhosphorylationSSGNAATSGNAATKI
CCCCCCCCCCCCCCC
25.8929116813
640PhosphorylationATSGNAATKIPTPIV
CCCCCCCCCCCCCCE
27.3923312004
641AcetylationTSGNAATKIPTPIVG
CCCCCCCCCCCCCEE
41.8025953088
644PhosphorylationNAATKIPTPIVGVKR
CCCCCCCCCCEEEEC
29.1722985185
650AcetylationPTPIVGVKRTSSPHK
CCCCEEEECCCCCCC
43.9923954790
652PhosphorylationPIVGVKRTSSPHKEE
CCEEEECCCCCCCCC
28.0428176443
653PhosphorylationIVGVKRTSSPHKEES
CEEEECCCCCCCCCC
46.0028176443
654PhosphorylationVGVKRTSSPHKEESP
EEEECCCCCCCCCCC
30.3428176443
660PhosphorylationSSPHKEESPKKTKTE
CCCCCCCCCCCCCCC
43.0126055452
662SumoylationPHKEESPKKTKTEED
CCCCCCCCCCCCCCC
80.50-
662SumoylationPHKEESPKKTKTEED
CCCCCCCCCCCCCCC
80.50-
663SumoylationHKEESPKKTKTEEDE
CCCCCCCCCCCCCCC
59.65-
663SumoylationHKEESPKKTKTEEDE
CCCCCCCCCCCCCCC
59.65-
664PhosphorylationKEESPKKTKTEEDET
CCCCCCCCCCCCCCC
49.6928450419
666PhosphorylationESPKKTKTEEDETSE
CCCCCCCCCCCCCCC
50.2530576142
671PhosphorylationTKTEEDETSEDANCL
CCCCCCCCCCHHCCC
50.1425849741
672PhosphorylationKTEEDETSEDANCLA
CCCCCCCCCHHCCCH
31.2830108239
681PhosphorylationDANCLALSGHDKTEA
HHCCCHHCCCCHHHH
28.6030108239
685AcetylationLALSGHDKTEAKEQL
CHHCCCCHHHHHHHH
42.4626051181
686PhosphorylationALSGHDKTEAKEQLD
HHCCCCHHHHHHHHC
47.4330108239
698O-linked_GlycosylationQLDTETSTTQSETIQ
HHCCCCCCCHHHHHH
35.9528510447
699O-linked_GlycosylationLDTETSTTQSETIQT
HCCCCCCCHHHHHHH
29.8428510447
701O-linked_GlycosylationTETSTTQSETIQTAA
CCCCCCHHHHHHHHH
34.3228510447
713PhosphorylationTAASLLASQKTSSTD
HHHHHHHCCCCCCCC
31.98-
716PhosphorylationSLLASQKTSSTDLSD
HHHHCCCCCCCCHHH
21.9226846344
717PhosphorylationLLASQKTSSTDLSDI
HHHCCCCCCCCHHHC
37.9726846344
718PhosphorylationLASQKTSSTDLSDIP
HHCCCCCCCCHHHCC
31.0426846344
719PhosphorylationASQKTSSTDLSDIPA
HCCCCCCCCHHHCCC
40.5026846344
722PhosphorylationKTSSTDLSDIPALPA
CCCCCCHHHCCCCCC
35.9826846344
736AcetylationANPIPVIKNSIKLRL
CCCCCCCCCEEEEEC
44.8917172643
738PhosphorylationPIPVIKNSIKLRLNR
CCCCCCCEEEEECCC
18.9923401153
740AcetylationPVIKNSIKLRLNR--
CCCCCEEEEECCC--
27.6317172643

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of PAPOA_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PAPOA_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PAPOA_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HDAC1_HUMANHDAC1physical
17172643
HDAC3_HUMANHDAC3physical
17172643
HDA10_HUMANHDAC10physical
17172643
SIR1_HUMANSIRT1physical
17172643
SIR2_HUMANSIRT2physical
17172643
CPSF6_HUMANCPSF6physical
17172643
CPSF5_HUMANNUDT21physical
17172643
IMB1_HUMANKPNB1physical
17172643
PP1B_HUMANPPP1CBphysical
22939629
GNA11_HUMANGNA11physical
26186194
ARBK1_HUMANADRBK1physical
26344197
CSTF2_HUMANCSTF2physical
26344197
CSTFT_HUMANCSTF2Tphysical
26344197
CSTF3_HUMANCSTF3physical
26344197
ROA1_HUMANHNRNPA1physical
26344197
SPT5H_HUMANSUPT5Hphysical
26344197
CIRBP_HUMANCIRBPphysical
26496610
RSRC1_HUMANRSRC1physical
26496610
RASN_HUMANNRASphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PAPOA_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-534 AND SER-537, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553, AND MASSSPECTROMETRY.

TOP